Lepow and associates reported in 1954 (1) that the activation of the first component of complement (C1) 1 was associated with the capacity to inactivate the fourth (C4) and to a lesser degree the second (C2) components of human complement in the pseudoglobulin fraction of serum. These results were later confirmed with partially purified preparations of human C1 (2), with eluates of immune aggregates pretreated with fresh human serum (3), and with a highly purified Cls fraction of the C1 macromolecule (4). More recently, Miiller-Eberhard and Lepow (5) have described physicoehemical changes in isolated C4 following interaction with highly purified Cls.
(Received for publication 11 November 1968) Lepow and associates reported in 1954 (1) that the activation of the first component of complement (C1) 1 was associated with the capacity to inactivate the fourth (C4) and to a lesser degree the second (C2) components of human complement in the pseudoglobulin fraction of serum. These results were later confirmed with partially purified preparations of human C1 (2) , with eluates of immune aggregates pretreated with fresh human serum (3) , and with a highly purified Cls fraction of the C1 macromolecule (4) . More recently, Miiller-Eberhard and Lepow (5) have described physicoehemical changes in isolated C4 following interaction with highly purified Cls.
The classical studies of Mayer and coworkers (6) clearly demonstrated that cell-bound first component, EAC1, could not uncover the binding site of C2 unless C4 was already fixed to the cell, EAC14. Subsequently, Becket (7) estabfished that the esterafic activity of C1 must be intact for the EAC14 intermediate to interact with C2 so as to achieve the EAC142 state. This was confirmed by Stroud, Austen, and Mayer (8) with the demonstration that the interaction of EAC14 intermediate with C2 was associated with the appearance of an altered, hemolytically inactive form of C2 in the fluid phase. Neither the altered form of C2 nor the EAC142 intermediate developed if the enzymatic activity of the EAC14 complex was inactivated by pretreatment with diisopropyl fluorophosphate (DFP). Fragments of individual components are subscripted with letters. The activated forms of the components are assumed to exist in intermediate cellular complexes unless otherwise specified. In addition to these conventions, the species of origin of a given component is indicated by a superscript (hu, human; gp, guinea pig). SAC14 and SAC142 refer to the proportion of hemolyticaUy active sites formed per erythrocyte during the interaction of EAC1 with C4 and EAC14 with C2, respectively. 679
Miiller-Eberhard (9, 10) has established that native C4 and C2 isolated from human serum can interact reversibly under defined conditions, and that the product of the action of Cls on C4 and C2 is a new enzyme, consisting of inactivated C4 (C4i) and a fragment of C2 (C2a) termed C3 convertase. Although it is clear that C4 is a natural substrate of C1 and their interaction must precede the participation of C2 in the hemolytic sequence, the nature of the process by which C4 facilitates the interaction of C1 with C2 is not established.
The present studies examine the interaction of C1 and C2 in the fluid phase and demonstrate that homologous C4 enhances the inactivation of C2 by C1, whereas heterologous C4 is inhibitory. Thus, in the fluid phase as on the cellular intermediate, C4i is essential to the specific action of C1 on C2.
Materials and Methods
The sources and methods of handling of sheep erythmcytes, guinea pig serum, and human sera have been described (11) . The methods for preparing Veronal-buffered saline, pH 7,5, 0.145 M, containing 0.1% gelatin, 0.00015 M Ca ++ and 0.0005 M Mg ++ (GVB++), and dextrose-Veronal-buffered saline, 0.075 M, with the same concentrations of gelatin and cations (D-GVB ++) have been reported (12) . Disodinm ethylenediamlnetetraacetate (EDTA) buffers in GVB were prepared to a final concentration of 0.01 M and 0.04 M EDTA (13) . The sources and method of preparation of diethylaminoethyl (DEAE)-and carboxymethyl (CM)-celluloses, and the buffers used with them, have been previously described (13) . Diisopropyl fluorophosphate (DFP), molecular weight 184.15, reagent grade (Aldrich Chemical Co., Inc., Milwaukee, Wis.) was used as described by Becker (7).
Prepara~on of Human and Guinea Pig Components of Complement.-
Human and guinea pig first component: C1 h~ and CI~P were precipitated at pH 7.5, with a conductivity equivalent to 0.04 M NaCI, as described by Nelson et al. (13) and Vroon and Nelson. ~ The precipitate formed was washed in saline phosphate buffer at the same pI-I and ionic strength, redissolved in 0.3 M NaCI in 0.005 M phosphate buffer, p i t 7.5, and reprecipitated and redissolved again using the same buffers. Further purification was obtained by filtration through Sephadex G-200 equilibrated with 0.15 ~t NaC1 in 0.005 M phosphate buffer, pI:I 7.5 (14) . The C1 activity was contained in an elution volume equivalent to the first protein peak obtained when whole serum was applied to the column.
Human and guinea pig fourth component:
The techniques of Vroon and Nelson 2 and Nelson et al. (13) were used. After precipitation of the euglobulins from 100 ml of human serum or guinea pig serum by procedures identical with those described above for C1, the supernatant was adjusted to ionic strength 0.120 M NaCI and applied to a DEAE-celiulose column (5.0 X 50 era) equilibrated at pFI 7.5, 0.120 M NaC1. When the application of the protein was completed, the column was washed with starting buffer until the optical density at 280 mt~ of the effluent was less than 0.050. A straight line gradient of increasing salt concentration was then applied. C4 eluted at 0.140--0.150 ~r NaC1 but was heavily contaminated with the inhibitor of CI esterase. Fractions containing C4 activity were pooled, adjusted to 0.090 NaC1 by dilution with distilled water and to pH 5.0 by the addition of 1.0 M acetic acid, and applied to a CM-celluiose column equilibrated at the same pI-I and ionic strength. The C1 esterase inhibitor passed through the CM-cellulose column in the effluent, and C4 was elated with a linear salt gradient at 0.120--0.130 M NaCI. The C4 preparations obtained by this technique ranged from 1 X 1011 to 5 X 10 ix effective molecules/ml and were free of functional activity of other components. Yields ranged from 10 to 25% of the C4 hu or C4~p measured in the original serum.
Human second component: The initial 0.120 ~s NaC1 effluent from the DEAE column used for the preparation of C4 hu contained C2 hu activity as well as the activities of the other complement components of the serum with the exception of C1, C4, and C9. The effluent fractions were pooled and brought to a final concentration of 2.2 ~ (NI-I4)2SO4 by the addition of 4.0 ~ (NI-h)2SO4; this precipitated most of the complement components other than C2 hu and C8 h~. The supematant was dialyzed against several changes of phosphate buffer, 0.075 x~ NaC1, pH 7.5, adjusted to 0.080 x~ NaC1, pH 6.0, by the addition of 1.0 ~ acetic acid and applied to a CM-cellulose column which had previously been equilibrated at the same pH and ionic strength. After washing the colunm with starting buffer, a linear salt gradient was applied and C2 h" eluted at 0.120-0.130 M NaCI. 2 This procedure produced functionally pure C2 h~ with activities ranging from 2 × i0 x° to 6 X 10 ~° effective molecules/ ml, with yields of approximately 10% of the C2 ru activity of the original serum.
Guinea pig second component:
The supernatant fluid from the precipitation of C1 was adjusted to 0.075 K NaC1 and passed through a DEAE-cellulose column equilibrated at the same ionic strength and pH 7.5. All the C2 ~P activity was found in the initial effluent, which also contained C6 and some C7 activity. Fractions containing C2 activity were pooled, adjusted to pH 5.0, 0.075 M NaCI, and applied to a CM-cellulose column equilibrated at the same pH and ionic strength. The C2 ~ passed through this column with the effluent, and the C6 and C7 were retained. The final C2 preparation contained trace amounts of C7 as the only functional contaminant when tested by the techniques described by Nelson et al. (13) . The activity was 7.5 X 10 ~° effective molecules/ml and represented approximately 40% of the C2 ip activity of the original serum.
Human C1 inkibltor (C1 INK):
The techniques described by Gigli et al. (15) were used to isolate the C1 INH from human serum.
Cellular Intermediates of the Hemolytic System and Titration of Components of Complement.--
Sheep erythrocytes were coated with commercial anti-sheep hemolysin made in rabbits or with purified rabbit 19S antibody (EA) isolated from rabbits immunized with sheep E stromata. EAC1 gp ceils were prepared by mixing EA in D-GVB ++ with an equal volume of partially purified C1 gP diluted to provide 250 effective molecules/cell in the fluid phase; after incubation at 300C for 45 rain, the cellular intermediate was washed three times in D-GVB ++ and stored in the same buffer with penicillin and streptomycin (16) . EAC1 gp4 h~ were prepared from the EAC1 go cells either by the method described by Borsos and Rapp (17) or by incubating, at 30°C for 30 rain, EAC1 gp with purified C4 h~ diluted in D-GVB ++ to provide 200 effective C4 molecules]cell in the fluid phase. EAC4 h~ cells were obtained by incubating EAC1EP4 hu in 0.01 EDTA-GVB according to the method of Borsos and Cooper (18) . All cellular intermediates were washed and stored as described for EAC1 gP. The proeedures for the effective molecule titmtions of C1 (19) , C4 (16) , and C2 (20) , human or guinea pig, have been previously described.
RESULTS
The Fluid Phase Destruction of C4 h~ by Homologous and Heterologous C1.~ 0.5 ml samples of C4 hu, 4 units/ml, 8 were mixed with 0.5 ml of D-GVB ++ or 0.5 ml of a serial dilution of C1 hu or CI~ at concentrations ranging from 0.375 3 Concentration of components in the fuid phase is expressed as units/ml. One unit is the dilution sufficient to generate one hemolytically active site per cell at a concentration of 1 X 10 s cells/ml. the samples incubated for 60 rain at 37°C. Mter the addition of 4.0 ml of ice cold saline, the per cent lysis was determined (16). Fig. 1 shows that the conversion of EAC1 gp to EACI~p4 h~ by the residual C4 hu decreased as a linear function of the C1 hu present in the original mixture of C1 and C4. When CI*p was present in the mixtures, the destruction of C4 h~ was only 12 % of that produced by the same molecular concentration of C1 hu.
The kinetics of fluid phase destruction of C4 hu by C1 h~ and the possible changes in hemolytic activity of the C1 h~ during this reaction were studied in the following experiment. Three 5 ml samples of C4 h~, 4 units/ml, were preincubated at 30°C. At time zero, the samples received an equal volume of D-GVB ++, C1 hu, 0.8 units/roll, or C1 h", 0.6 units/mll, respectively. Immediately after mixing and at 5 min intervals thereafter, 0.5 ml samples were removed from each reaction mixture and added to 0.5 ml of E A C I~ for a titration of the residual hemolytically active C4 hu as described above. Duplicate 0.5 ml samples were removed at the same intervals and added to 0.5 ml of EAC4 h~ for titration of the residual hemolytically active C1 b~. These reaction mixtures were incubated for 30 rain at 30°C, followed by the addition of 0.5 ml C2w containing 100 effective molecules. After 15 min of incubation at 30°C, 0.5 ml of 0.04 M EDTA, followed by 1.0 ml of a 1:15 dilution of GPC in 0.04 ~ EDTA were added, and the samples further incubated for 60 rain at 37°C. After the addition of 4.5 ml ice cold saline, the per cent lysis was determined (19) . Control samples taken from two additional mixtures of the same starting C1 uu concentrations in D-GVB -H were analyzed for C1 hu in the same manner. Fig. 2 shows the residual C4 u~ and C1 h~ in each reaction mixture as measured by the formation of SAC14. With both C1 uu concentrations there was a linear decrease in C4 h~ activity during the 60 rain incubation. The C1 hu activity in the C1-C4 reaction mixtures was not reduced compared with C1 h~ incubated with buffer alone.
The Fluid Phase Destruction of C2 h" or C2 °~' by Homologous and tIeterologous C1.--1 ml samples of C2 au, 4 units/rnll, were mixed with 1 ml of D-GVB ~+ or serial dilutions of C1 h" or ClgP ranging from 106.25 to 1700 C1 units/ml. An identical series of reaction mixtures was prepared using C2*" instead of C2 h". Mter incubation for 30 rain at 30°C, a 0.5 ml aliquot was removed from each reaction mixture and added to 0.5 ml of EAClgp4 h". Mter incubation for 3 rain at 30°C, 1.5 ml of a 1:22.5 dilution of GPC in 0.04 ~ EDTA was added; the mixtures were incubated for 90 rain at 37°C and the per cent lysis determined (20) . Fig. 3 shows that the conversion of EAClw4 hu to EACI~4hu2 hu or EAClgp4h~2 *v by the residual C2 h~ or C2 *v in each reaction mixture decreased as a linear function of the C1 h~ or C I~ concentration. When C1 *~ was present in the mixtures, the destruction of C2 hu was only 12 % of that produced by the
.425 850 1700
C! (UnHs/m/)
Fro. 3. Fluid phase destruction of C2 hu or C2¢P by varying amounts of C1 h" or CI=~. Reaction of C2 hu with C1 hu (O) o r C l g p ( 0 ) , and of C2 sp with C1 hu (I-l) or C1 gp (m), were assessed by determining residual C2 by the conversion of EACI*p4 hu to EAClgP4hu2hu or EAC1 *P4h~2 =~. same molecular concentration of C1 hu. The concentrations of C1 selected were based on the preliminary finding that the destruction of C2 required more than 50 C1 unlts/ml.
The kinetics of fluid phase destruction of C2 hu by C1 h~ were studied with a wide range of C1 h" concentrations. Four 5 ml samples of C2 h~, 15 units/nil, were prcincubated at 30°C and then reacted with either 5 ml of D-GVB ++ or 5 ml of C1 h~ containing 50, 500, or 5000 units/ml. Immediately after mixing and at 5 min intervals thereafter, 0.5 rnl samples were removed and diluted to 5 ml with D-GVB++; 0.5 ml of each dilution was mixed with 0.5 ml of EACI*v4 h~ to determine the residual hemolytically active C2 hu, as described above. Fig. 4 shows the C2 hu hemolytic activity in the four reaction mixtures expressed as SAClgp4hu2 h~ formed. The C2 h~ activity in the samples incubated with buffer only remained constant throughout the 60 rain of incubation. When C1 h" conraining 50 unlts/ml was added, the loss of hemolytic activity reached only 12 % of the total C2 h" present. At a C1 h" concentration of 500 units~m], the C2 h" destruction proceeded at a faster rate; and in 60 win 90% of the C2 was no longer detectable. The same decrease in C2 activity was achieved in 7 rain when the concentration of C1 h" was increased to 5000 units/m]. In the three reaction mixtures, there was a lag phase of 3 mln during which C2 was stable regardless of the C1 h" concentration. The stability of C1 hu during this reaction was studied in a separate experiment where 125 units of C1 hu were incubated either with 10 units of C2 ~" or with D-GVB ++. The C1 h" activity was identical whether it was incubated with C2 h" or with buffer only.
The Fluid Phase Destruction of C2 h= by C1 h= in the Presence of C4h=.--Three 5 ml aliquots of C2 hu, 3 units/m], were incubated at 30°C with 5 ml of D-GVB ++, 2.5 ml D-GVB +~, and 2.5 ml C1 h" containing 500 units/ml, or 2.5 ml of the same C1 hu and 2.5 ml of C4~u containing 50 units/m]. Immediately and at 7.5 mln intervals, 0.5 ml aliquots were removed and added to 0.5 ml of EACI~4 hu for a titration of the residual functional C2 hu. The results shown in Fig. 5 reveal that in the presence of C4~u one-half of the functional C2 h~ is destroyed within 30 sec. Thereafter, the disappearance of hemolytically active C2 proceeds at a rate comparable to its loss in the mixture of C2 h~ and C1 hu alone.
To investigate the effect of the C4 h~ concentration on the fluid phase reaction of C1 hu and C2 hu, an experiment was performed in which a constant amount of C1 hu and a limited amount of C2 h~ were interacted in the presence of varying dilutions of C4 h~. Six 5 ml samples of C2 hu, 1.5 units/rnl, were incubated with 5 m] D-GVB ++, 2.5 ml D-GVB ++, and 2.5 ml C1 ~ containing 100 units/m], or with 2.5 m] of four different concentrations of C4 hu containing from 9.2 to 250 units/ml and 2.5 ml of the same C1 h" (100 units/ml). All the dilutions were prewarmed at 30°C and mixed in the order described. Immediately and at varying time intervals, as designated in Fig. 6 , 0.5 ml samples were removed and added to 0.5 rnl of EACI*p4 h" for a titration of hemolytically active C2 h~. The results reveal that increasing concentrations of C4 h~ in the reaction mixtures are associated with an increasingly rapid initial destruction of C2 uu by C1 h". The finding that the action of C1 u~ on C2 hu in the absence of additional C4 h" also had an initial, more rapid, slope may indicate contamination of this C1 u~ preparation with C4 h" not detected by functional titration. C2 uu incubated with buffer remained constant throughout the experiment. Additional control mixtures of C4 h~ and C2 h" without C1 revealed that the amounts of C4 hu used in this experiment had no effect on the activity of C2 compared to the C2 hu sample incubated with buffer.
The Fluid Phase Destruction of C2 h~' by C1 h" in the Presence of C4 Previously
Inactivated by Exposure to Clh".--The observation that the destruction of C2 hu by C1 h" in the presence of C4 h~ had an initial rapid and subsequent slow phase introduced the possibility that the rapid phase was dependent upon the presence of hemolytically active C4. An experiment was performed to determine the effect of hemolyfically active and inactive C4 on C2 destruction by C1. C4 hu, 50 units/ml, was incubated at 30°C with an equal volume of C1 h", 100 units/ml.
Immediately upon mixing and at varying times thereafter, duplicate 0.5 ml samples were removed. One sample was diluted 10-fold in D-GVB ++, and 0.5 ml of this dilution was added to 0.5 ml of EAC1 cells to measure the residual hemolyticaUy active C4. The second sample was added to 0.5 ml of C2 h~, 2 units/ml, and the mixture incubated for 30 rain at 30°C; 0.5 ml of EACI*p4 h~ was then added to determine the residual hemolytically active C2 hu. Two control samples of C2 hu received either 0,5 ml D-GVB ++ or 0.5 ml of C1 hu at a concentration equal to that in the Clhu-C4 hu mixture. Fig. 7 shows that C2 hu incubated with buffer alone generated 2.0 SAC142, C2 hu incubated with C1 h" yielded 1.55 SAC142, while C2 hu incubated with the Clh~-C4h" mixture yielded only 0.65 SAC142 at a time when the C4 was hemolyfically inactive. The residual C2 h" exposed to the Clhu-C4 h~ mixture at zero time, when C4 hu was fully hemolyfically active yielded 0.82 SAC142. Thus, the Clh"-C4 h" mixture was capable of destroying C2 h~ in the fluid phase at a time when the C4 h" was inactivated (C4i) by prior exposure to C1 hu. presence of C4i, it was necessary to examine the effect of C4i on C2 activity. C4i was produced by the interaction of 1 ml C4 hu, 50,000 units/ml, and 1 ml of C1 hu, 60,000 units/ml, for 30 rain at 30°C. A second sample of 1 ml C4, 50,000 units/ml, was incubated with 1 ml D-GVB ++. 1 ml of the C4i and 1 ral of the control C4 received DFP to a final concentration of 0.005 M/ml. All four samples, C4, C4 treated with DFP, C4i-C1 hu, and C4i-C1 h" treated with DFP, were incubated for 10 rain at 30°C, followed by dialysis against three 1000 ml D-GVB ++ changes. 0.5 ml of serial dilutions of each of the four mixtures was then mixed with 0.5 ml of C2 hu, 2.2 units/ml. After 30 min of incubation at 30°C, 0.5 ml of EAC14 ceils was added to determine the residual hemolytically active C2 h". As shown in Fig. 8 , the C2 incubated with D-GVB ++ alone yielded 2.1 SAC142. The C2 incubated with the 1:300 dilutions of C4, C4 pretreated with DFP, or C4i-C1 h~ pretreated with DFP yielded 2.1, 1.93, and 1.8 SAC142, respectively; whereas C2 incubated with C4i-C1 h" yielded only 0.73 SAC142. The CI h" activity in the C4i-CI mixture was the same as that found in the sample of CI h~ added to form the mixture, whereas the C4i-CI h" treated with DFP had lost 98 % d the C1 h" activity. The C4i-CI mixtures with or without DFP treatment had no demonstrable C4 hemolytic activity, while the activity in the C4 samples with and without DFP treatment was the same as that added at the start of the experiment. These data reveal that the destruction of C2 h" facilitated by C4i requires enzymatically active CI.
The Inability to Achieve Fluid Phase Destruction of C2 h" in the Presence
This point was examined further by employing C1 INH in place of DFP to inhibit C1. Three I In] samples of C1 hu, 222 tmits/ml, were incubated for 30 min at 30°C with an equal volume of two dilutions of CI INH containing 300 and 600 units/ml respectively, or with D-GVB ++. 1 ml of C@ u, 160 units/ml, and 1 ml of C2 h", 45 units/ml, were then added. A control sample of CI hu and a control sample of C4h~-C2 hu mixture were prepared to give the same concentration as was contained in the experimental tubes. After 30 rain at 30°C, dilutions of the five reaction mixtures were fitrated for C1 h~, C4 hu, and C2 h~ hemolytic activity. The results in Table I reveal that the concentration of inhibitor selected, 300 and 600 units/ml, permitted the reduction of C4 h~ to 0 and 15.5 units/ml, respectively, from a starting level of 160 units/ml, even though the C1 hu activity had been reduced from 222 to 7.2 and 2.8 units/ml, respectively. On the other hand, the C2 activity which was reduced from 45 to 4 units/ml by the presence of C1 and C4 was protected almost completely by both concentrations of inhibitor.
The Fluid Phase Destruction of C2 h" by C1 h" in the Presence of Homologous and
Heterologous C4.--The species specificity of the enhancement effect of C4 upon C2 h" destruction by C1 hu was studied by comparing the effect of C4~ with C4 h~. Four 2 rnl samples of C2 hu, 6 units/re_l, were mixed with 4 ml D-GVB++; 15.5 2 ml D-GVB ++ and 2 ml of C1, 60 units/ml; 2 ml C4 hu, 100 units/ml, and 2 ml of the same Clhu; or 2 ml C4~, 100 units/ml, and 2 ml C1 hu. The four mixtures were incubated at 30°C. Immediately and at varying time intervals, 0.5 ml samples were removed and added to 0.5 ml of EAClgp4 hu to determine residual hemolytically active C2. As shown in Fig. 9 , after 30 min of incubation the C2 hu in buffer yielded 1.95 SAC142; that exposed to C1 hu, 1.25 SAC142; and that exposed to C1 hu in the presence of homologous C4, 0.58 SAC142. When C2 h~ was exposed to C1 h~ in the presence of heterologous C4, there was no loss of C2 h~ in that 2.0 SAC142 were formed. C1 hu titrations of the three mixtures containing this component revealed no loss of its activity, and thus the protection afforded by heterologous C4 cannot be attributed to the presence of C1 I N H in this preparation. The finding that C2 destruction by C1 was enhanced by homologous C4 and prevented by heterologous C4 prompted studies on the effect of mixtures of homologous and heterologous C4 on the C2 h~ destruction by C1 h~. Five 1 ml samples of C2, 2.6 units/ml, were incubated at 30°C. Two of these samples received 1 ml C4 hu, 100 units/ml; two received 1 ml C4gp, 100 units/ml; and one received 2 ml D-GVB ++. After a 10 min incubation, 1 ml of either C4g,, 100 units/ml, or 1 ml D-GVB ++ was added to the samples containing C2hu-C4hu; and 1 ml C4 h", 100 units/ml, or 1 ml D-GVB ++ to the mixtures of C2hu-C4 ~. After a 10 rain incubation at 30°C, 1 ml C1 h", 200 units/ml, was added to the five reaction mixtures. A control sample containing 1 ml C2, 3 units/ml, was mixed with 3 ml D-GVB ++. After 30 min at 30°C, 0.5 ml was removed from the six samples and added to 0.5 ml of EACI~4 h" to determine the residual hemolytically active C2 hu. Fig. 10 shows that the C2 incubated with buffer yielded 0.87 SAC142 (A); that exposed to C1 h", 0.39 SAC142 (E); and that exposed to C1 hu in the presence of homologous C4, 0.19 SAC142 (F). The substitution of heterologous for homologous C4 generated 0.92 SAC142 (B). When homologous and heterologous C4 were present in equal concentrations, regardless of the order of their addition, there was partial protection in that 0.56 SAC142 (C, D) was generated.
The competition of homologous and heterologous C4 was also examined in a kinetic experiment. Five samples of 1 ml C1 hu, 100 units/ml, were incubated at 30°C. Two of these samples received 1 ml C4 hu, 200 units/ml; two received I ml C4~, 200 units/ml; and one was mixed with 2 ml D-GVB ++. After 10 min of incubation at 30°C, 1 ml of either C4~, 200 units/ml, or D-GVB ++ was added to the samples containing Clhu-C4hu; and 1 ml C4 h~, 200 units/ml, or 1 ml D-GVB ++ was added to the samples containing Clhu-C4~. All five experimental mixtures received 1 ml C2 h", 4 units/ml. Control samples included C2 hu alone, C2 hu mixed with C4~, and C2 hu mixed with C4 hu. A t zero time and at varying time intervals, 0.5 ml samples were removed and added to 0.5 ml of E A C I~4 bu to titrate the residual hemolytically active C2 h~. As shown in Fig. 11 , the re- sidual C2 hu after incubation in buffer generated 0.96 SAC142; the presence of homologous or heterologous C4 with C2 h~ yielded the same or an increased number of SAC142. Exposure of the C2 hu to C1 h~ alone reduced the sites produced to 0.65. C1 h" in the presence of homologous C4 reduced the C2 h~ so that only 0.26 SAC142 was generated, whereas the substitution of heterologous C4 protected C2 as indicated by the formation of 1.3 SAC142. The mixture of homologous and heterologous C4 afforded the same partial protection irrespective of the order of addition.
DISCUSSION
The present studies demonstrate that in the fluid phase C4 hu is highly susceptible to inactivation by C1 ha, whereas C2 hu is relatively resistant unless C4 hu is also present in the mixture. These results extend the early observations of Lepow et al. (1) that the activation of C1 is associated with the capacity to inactivate C4 and to a lesser degree C2 in the pseudoglobuiin fraction of human serum. In these early experiments no attempt was made to examine the action of C1 on C2 alone; thus the contribution of C4 has not been previously assessed in fluid phase mixtures.
Six units of C1 hu were capable of inactivating 75% of 4 units of C4 h~ in 20 rain (Fig. 1) , whereas approximately 850 units of C1 hu were required to produce a similar inactivation of 4 units of C2 hu in the same time period (Fig. 3) . Kinetic experiments again revealed the susceptibility of C4 to inactivation by small amounts of C1, 0.6-0.8 units (Fig. 2) ; whereas inactivation of 15 units of C2 hu was negligible with 50 units of C1 hu and required 500-5000 units for a striking effect (Fig. 4) . Even at 5000 units, there was a lag phase to the action of C1 hu on C2 hu (Fig. 4) which was not apparent when inactivation of C4 hu was examined (Fig. 2) .
When 50 units of C1 hu were interacted with C2 h~ in the presence of C4 hu, an increasing capacity to destroy C2 was demonstrable (Fig. 6 ). In the presence of C4 h~, the inactivation of C2 hu by C1 hu no longer exhibited a lag phase (Fig.  5) . Instead there is an initial rapid disappearance of functional C2 in an interval of less than 5 m~n and comparable to that previously occupied by the lag phase (Figs. 4-5 ). After completion of the rapid phase of inactivation, C2 hu inactivation proceeds at a rate comparable to its loss by the action of C1 hu alone. The magnitude of the rapid phase inactivation of C2 hu by C1 hu in the presence of C4 h~ is related to the supply of C4 hu. As shown in Fig. 6, 4 .6 units of C4 hu permit approximately 30.5% inactivation; 13.2 units, 43% inactivation; 41.6 units, 50% inactivation; and 125 units, 84% inactivation of 1.5 units C2 h~ by 50 units of C1 within 5 rain.
The finding that the enhanced inactivation of C2 h~ by C1 hu in the presence of C4 hu occurs within the first few minutes of interaction suggested a dependence upon the presence of hemolytically active C4 hu. Accordingly, an experiment was conducted in which C1 hu and C4 h" were interacted for varying time intervals prior to the addition of this mixture to hemolyticaUy active C2 h". The hemolytically active C4 h~ was inactivated (C4i) within 5 rain of C1 h" exposure, yet the reaction mixture Clh"-C4i h" at that time and at various intervals thereafter was fully active in destroying C2 (Fig. 7) . Indeed the Clh~-C4P" mixtures had slightly greater inactivating capacity than the initial Clhu-C4h~ mixture. Thus, the enhancement effect of C4 hu on the action of C1 h~ on C2 h~ occurs during the period of C4 hu inactivation and is manifested fully when all the native C4 has been converted to C4i.
The classical studies of Mayer and coworkers (6, 21) have clearly demonstrated that cell-bound first component, EAC1, does not uncover the binding site of C2 unless C4 is already fixed to the cell. Subsequently, Becker demonstrated (7) that the esteratic site of C1 must be intact for the EAC14 intermediate to interact with C2 to achieve the hemolytically active EAC142 state. Miiller-Eberhard has presented evidence that the state of the fourth component in the hemolytically active intermediate is C4i (9, 10) . Thus, it was important to demonstrate that the enhanced fluid phase inactivation of C2 hu by C1 hu in the presence of C4i hu occurred only when the esteratic site of C1 h~ was intact. C1 h~ inactivated by DFP had no effect on hemolytically active C2 h~ even in the presence of C4i (Fig. 8) . When the C1 I N H was employed to inhibit C1 hu, the C4 h~ in the reaction mixtures was inactivated, but there was no enhanced destruction of C2 h~ (Table I) . These studies of DFP-inactivated or C1 INH-blocked first component reveal that the fluid phase inactivation of C2 hu by Clh~-C4i mixtures requires hemolytically active C1. These same experiments ( Fig. 8 and Table I ) demonstrate that the disappearance of hemolytically active C2 h~ from the reaction mixture on addition of C4 h~ or C4i hu is not explained by some direct effect of C4 h~ or C4i hu on C2 h~. The enhanced inactivation of C2 h~ by C4 h~ or C4i h~ occurs only in the presence of enzymatically active C1 hu and not when the esteratic site of C1 hu is blocked by C1 I N H or DFP. Further, in the experiment depicted in Fig. 6 , which involved the addition of increasing amounts of C4 hu to a limited amount of C2 h~, the loss of C2 h~ was related to the supply of C4 h~ only when C1 was present; there was no reduction in the hemolytic C2 hu on addition of increasing amounts of C4 hu alone.
It has been previously demonstrated by Nelson (22) and confirmed by Austen and Russell (23) that the cellular intermediate EACI*p4gp will not interact with C2 h~ so as to achieve a hemolytically active EAC142 intermediate. It was therefore of interest to examine the action of C1 *~ on functionally pure C4 h~ and C2 hu and the effect of C4~ on the action of C1 h~ on C2 h~. At comparable hemolytic units, CI*p inactivates C4 ~ (Fig. 1) or C2 hu (Fig. 3) to a much lesser extent than can be achieved with C1 h~. Not only did C4*p fail to enhance the action of C1 hu on C2 hu (Fig. 9) , hut it actually protects the C2 hu from inactivation by C1 hu (Figs. 10, 11 ). Although this protection could represent the failure of C1 hu to utilize C4*p, the finding that heterologous C4 interferes with the action of a Clhu-C4ihu mixture on C2 h~ indicates interference at the latter step as well.
The enhanced disappearance of functionally active C2 hu by the combined action of C1 h~ and C4i hu could involve either a change in the enzyme specificity or an alteration of substrate susceptibility. Mayer et al. (24) have demonstrated the binding of C2 to cell-bound C4, presumably C4i; and Miiller-Eberhard et al. (9) have demonstrated the formation of C4i-C2 complexes by physicochemical techniques. Thus it is possible that C4i alters C2 so as to present a more susceptible substrate to the C1 enzyme. Alternatively or in addition, C4 hu may, through an allosteric action on C1 hu, uncover a specificity for native C2 hu. Irrespective of the mechanism, a role of C4 hu is specifically to enhance the action of C1 hu on C2 h~ in the fluid phase.
SUMMARY
The fluid phase inactivation of C2 h" by C1 b" is markedly enhanced by the presence of C4 h~. The enhancement is afforded by C1 inactivated C4 hu, namely C4i h", and requires the simultaneous presence of enzymatically active C1. Heterologous C4 of guinea pig origin protects C2 hu from the inactivation by C1 hu. Thus, in both the fluid phase and on the cellular intermediate, C4i h" is essential to the specific action of C1 h" on C2 h". It is possible that C4i alters C2 so as to present a more suitable substrate to the C1 enzyme or that C4i acts on the C1 to uncover a specificity for native C2.
